← Open Payments lookup

SRINIVAS RANGU: Open Payments

NPI 1902963655 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$459 in 28 payments from 12 companies in 2025. Trend: 2023 $469 · 2024 $598 · 2025 $459

Food & beverage: $459
CompanyPaymentsAmount
GlaxoSmithKline, LLC.11$156
Sumitomo Pharma America, Inc.6$100
PFIZER INC.2$38
Novartis Pharmaceuticals Corporation1$25
ABIOMED1$23
Otsuka America Pharmaceutical, Inc.1$22
Bayer Healthcare Pharmaceuticals Inc.1$20
Boehringer Ingelheim Pharmaceuticals, Inc.1$18
Kowa Pharmaceuticals America, Inc.1$17
Amgen Inc.1$16

Products named: TRELEGY ELLIPTA, GEMTESA, LEQVIO, REXULTI, VYNDAQEL, Kerendia, JARDIANCE, ELIQUIS.

Industry payments across TX — which companies pay providers there.